OTHER NEWS - March 11, 1994

Amgen Inc., Amcell Corp. Announce Collaboration: The companies said they have agreed to develop and commercialize products based on proprietary cell separation and characterization technology developed in Germany. The agreement gives Amgen, the Thousand Oaks-based biotechnology giant, exclusive worldwide rights to develop and commercialize certain cell-separation products developed by Amcell of Los Altos. Amgen said it made an equity investment in Amcell, but neither company would disclose financial terms. Amcell will receive research and development funds as well as payments from Amgen. The companies said the technology may be instrumental in future treatments for cancer, AIDS and other diseases.